NCT03939078View on ClinicalTrials.gov

CO2 Laser in the Treatment of the GSM - (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopause

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

October 5, 2019

Study Completion Date

March 5, 2020

Conditions

MenopauseVaginal AtrophyUrinary Incontinence

Interventions

RADIATION

CO2 fractional ablative laser

3 intravaginal fractional ablative CO2 laser sessions, with one month interval between them.

Trial Locations (1)

24033-900

Hospital Universitario Antonio Pedro, Niterói

All Listed Sponsors

collaborator

Alma Lasers

INDUSTRY

lead

Universidade Federal Fluminense

OTHER

NCT03939078 - CO2 Laser in the Treatment of the GSM - (Genitourinary Syndrome of Menopause) Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter